MRPS2 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to MRPS2 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes	PHASE4	UNKNOWN
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision	PHASE3	COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia	PHASE2	COMPLETED
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma	PHASE2	COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer	PHASE1	COMPLETED
Mitoquines in COPD	nan	UNKNOWN
Natural History and Genetic Studies of Usher Syndrome	nan	COMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases	nan	UNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact	nan	UNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study)	nan	COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma	nan	COMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)	nan	RECRUITING
Uncovering the Etiologies of Non-immune Hydrops Fetalis	nan	ENROLLING_BY_INVITATION
Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)	nan	COMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.	nan	UNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients	nan	UNKNOWN
Study of Usher Syndromes, Type 1 and Type 2	nan	COMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic	nan	COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia	nan	NOT_YET_RECRUITING
Protein Synthesis in the Brain of Patients With Fragile X Syndrome	nan	COMPLETED
miR-155 Expression in Episodic and Chronic Migraine	nan	UNKNOWN
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing	nan	RECRUITING
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
Genetic Analysis of Gray Platelet Syndrome	nan	COMPLETED
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Study of Specimens From Young Patients With Neuroblastoma	nan	COMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide	nan	RECRUITING
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress	nan	WITHDRAWN

Related proteins — ESM-2 sequence neighbours (a MRPS2 binder may also engage these)

Protein	Name	Similarity
Q924T2	—	0.992	Q924T2 →
P82923	—	0.984	P82923 →
Q4FZX0	—	0.963	Q4FZX0 →
Q4V7A9	—	0.962	Q4V7A9 →
ABHD16A	Phosphatidylserine lipase ABHD16A	0.961	landscape →
A4D1U4	—	0.959	A4D1U4 →
Q6MG55	—	0.959	Q6MG55 →
Q5CZL1	—	0.958	Q5CZL1 →
Q80YD1	—	0.958	Q80YD1 →
Q5R6S0	—	0.958	Q5R6S0 →
Q4KLI9	—	0.958	Q4KLI9 →
Q68EN5	—	0.958	Q68EN5 →
Q1JPD2	—	0.957	Q1JPD2 →
LPCAT1	Lysophosphatidylcholine acyltransferase 1	0.957	landscape →
Q9NXN4	—	0.957	Q9NXN4 →
Q3UHG7	—	0.957	Q3UHG7 →
E9Q4Z2	—	0.957	E9Q4Z2 →
Q9Z1Q2	—	0.957	Q9Z1Q2 →
Q2KIX2	—	0.957	Q2KIX2 →
Q0PGW2	—	0.957	Q0PGW2 →
Q5EBA1	—	0.956	Q5EBA1 →
Q8IYB8	—	0.956	Q8IYB8 →
P82922	—	0.956	P82922 →
MAP4K2	Mitogen-activated protein kinase kinase kinase kinase 2	0.956	landscape →
Q08BI9	—	0.956	Q08BI9 →
Q1HAQ0	—	0.956	Q1HAQ0 →
Q0V8R7	—	0.956	Q0V8R7 →
EIF2B5	Translation initiation factor eIF2B subunit epsilon	0.956	landscape →
Q8N3Z3	—	0.955	Q8N3Z3 →
Q8NFZ0	—	0.955	Q8NFZ0 →